Literature DB >> 10206607

Lower urinary tract dysfunction and disability status in patients with multiple sclerosis.

A Giannantoni1, G Scivoletto, S M Di Stasi, M G Grasso, E Finazzi Agrò, G Collura, G Vespasiani.   

Abstract

OBJECTIVE: To investigate the correlation between neurologic and urologic status in patients with multiple sclerosis (MS).
MATERIALS AND METHODS: Between January 1993 and December 1995, 116 patients with MS symptoms were fully assessed neurologically and urologically with urodynamic studies.
RESULTS: Urodynamic abnormalities were detected in 104 patients (89.6%). Several significant relationships between urinary tract findings and neurologic dysfunction were: (1) the relation between voiding disorder as the presenting symptom of the disease and a higher severity of bladder dysfunction; (2) the relation between reduced bladder sensation and longer duration of voiding disorders, lower detrusor uninhibited contractions threshold, and lower bladder capacity; and (3) the relation between voiding disorders and cerebellar system score. Finally, a significant inverse relationship was found between detrusor hypocontractility and neurologic status (from the Expanded Disability Status Scale, pyramidal system score, and Barthel Index).
CONCLUSIONS: In this series a high incidence of patients reported voiding disorder as the presenting symptom of MS. These patients also showed a higher severity of urodynamic disorders. They should be rigorously followed up. Furthermore, our data suggest that although the most common cause of altered bladder control in MS is spinal cord pathology, involvement of cortical centers and/or peripheral neuronal lesions may occur.

Entities:  

Mesh:

Year:  1999        PMID: 10206607     DOI: 10.1016/s0003-9993(99)90282-4

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  12 in total

1.  Effects of pregnancy and child birth on urinary symptoms and urodynamics in women with multiple sclerosis.

Authors:  Aurélie Durufle; Sabine Petrilli; Benoit Nicolas; Sandrine Robineau; François Guillé; Gilles Edan; Philippe Gallien
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-05

2.  Dynamics of the sensory response to urethral flow over multiple time scales in rat.

Authors:  Zachary C Danziger; Warren M Grill
Journal:  J Physiol       Date:  2015-06-30       Impact factor: 5.182

Review 3.  TRP channels in lower urinary tract dysfunction.

Authors:  J Franken; P Uvin; D De Ridder; T Voets
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

4.  Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases.

Authors:  A Wiedemann; M Kaeder; W Greulich; H Lax; J Priebel; R Kirschner-Hermanns; I Füsgen
Journal:  World J Urol       Date:  2012-01-07       Impact factor: 4.226

Review 5.  Management of neurogenic bladder in patients with multiple sclerosis.

Authors:  Véronique Phé; Emmanuel Chartier-Kastler; Jalesh N Panicker
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

6.  Urinary dysfunction in women with multiple sclerosis: analysis of 61 patients from rio de janeiro, Brazil.

Authors:  Camila Rodrigues de Almeida; Kennedy Carneiro; Rossano Fiorelli; Marco Orsini; Regina Maria Papais Alvarenga
Journal:  Neurol Int       Date:  2013-11-11

7.  Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.

Authors:  Sanghee Lee; Balachandar Nedumaran; Joseph Hypolite; Brian Caldwell; Michael C Rudolph; Anna P Malykhina
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

8.  Neuromodulation for functional bladder disorders in patients with multiple sclerosis.

Authors:  Mohammad Sajjad Rahnama'i
Journal:  Mult Scler       Date:  2019-12-09       Impact factor: 6.312

9.  Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study.

Authors:  Kyla A McKay; Helen Tremlett; John D Fisk; Scott B Patten; Kirsten Fiest; Lindsay Berrigan; Ruth Ann Marrie
Journal:  Mult Scler       Date:  2015-08-05       Impact factor: 6.312

10.  Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.

Authors:  Daniel S Engeler; Daniel Meyer; Dominik Abt; Stefanie Müller; Hans-Peter Schmid
Journal:  BMC Urol       Date:  2015-10-23       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.